From: Role of contrast-enhanced spectral mammography in the assessment of residual disease following neoadjuvant chemotherapy in patients with breast cancer
Minimal diameter
Maximal diameter
Mean ± SD
CESM pre-NAC (cm)
1.3
15.0
6.0 ± 3.6
CESM post-NAC (cm)
0.0
11.0
3.63 ± 3.1
Histopathology post-NAC (cm)
3.7 ± 2.9